Ryman Healthcare (ASX:RYM) delivered NZ$188m positive free cash flow in FY26, its first in a decade, with EBITDAF up 94% and a FY28 dividend pathway in view.
26
Skip to content
Skip to sidebar
Skip to footer
Stocks in Spotlight
View all →-
AI Stocks · Semiconductor stocks SanDisk (NASDAQ:SNDK) The Sell Case Behind a 3,300% AI Memory Rally May 21, 2026 -
AI Stocks · Blue Chip Stocks Life360 (ASX:360): Ad Revenue Jumped 329%, So Why Did the Stock Fall? May 12, 2026 -
Tech Stocks · Growth Stocks Powerhouse Ventures (ASX:PVL) An Overlooked Deep Tech Platform Ripe for a Rerate May 6, 2026
